187 related articles for article (PubMed ID: 17152926)
1. Aspects of the cytological activity of edelfosine, miltefosine, and ilmofosine in Leishmania donovani.
Azzouz S; Maache M; Dos Santos MF; Sarciron ME; Petavy AF; Osuna A
J Parasitol; 2006 Oct; 92(5):877-83. PubMed ID: 17152926
[TBL] [Abstract][Full Text] [Related]
2. Leishmanicidal activity of edelfosine, miltefosine and ilmofosine.
Azzouz S; Maache M; Garcia RG; Osuna A
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):60-5. PubMed ID: 15667597
[TBL] [Abstract][Full Text] [Related]
3. Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis.
Santa-Rita RM; Henriques-Pons A; Barbosa HS; de Castro SL
J Antimicrob Chemother; 2004 Oct; 54(4):704-10. PubMed ID: 15329361
[TBL] [Abstract][Full Text] [Related]
4. Effect of alkyl-lysophospholipids on some aspects of the metabolism of Leishmania donovani.
Azzouz S; Maache M; Sánchez-Moreno M; Petavy AF; Osuna A
J Parasitol; 2007 Oct; 93(5):1202-7. PubMed ID: 18163358
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
[TBL] [Abstract][Full Text] [Related]
6. Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction.
Verma NK; Singh G; Dey CS
Exp Parasitol; 2007 May; 116(1):1-13. PubMed ID: 17161839
[TBL] [Abstract][Full Text] [Related]
7. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
[TBL] [Abstract][Full Text] [Related]
8. Study of the stress proteins secreted by Leishmania donovani after treatment with edelfosine, mitelfosine and ilmofosine, and morphological alterations analyzed by electronic microscopy.
Azzouz S; Maache M; Sarciron ME; Petavy AF; Osuna A
Parasite; 2009 Sep; 16(3):215-21. PubMed ID: 19839267
[TBL] [Abstract][Full Text] [Related]
9. Leishmania donovani: oral therapy with glycosyl 1,4-dihydropyridine analogue showing apoptosis like phenotypes targeting pteridine reductase 1 in intracellular amastigotes.
Kaur J; Singh N; Singh BK; Dube A; Tripathi RP; Singh P; Singh N
Exp Parasitol; 2010 Jul; 125(3):310-4. PubMed ID: 20219462
[TBL] [Abstract][Full Text] [Related]
10. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
Croft SL; Snowdon D; Yardley V
J Antimicrob Chemother; 1996 Dec; 38(6):1041-7. PubMed ID: 9023651
[TBL] [Abstract][Full Text] [Related]
11. Possible mechanism of miltefosine-mediated death of Leishmania donovani.
Verma NK; Dey CS
Antimicrob Agents Chemother; 2004 Aug; 48(8):3010-5. PubMed ID: 15273114
[TBL] [Abstract][Full Text] [Related]
12. Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death.
Mishra J; Singh S
Exp Parasitol; 2013 Oct; 135(2):397-406. PubMed ID: 23968687
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent.
Seifert K; Escobar P; Croft SL
J Antimicrob Chemother; 2010 Mar; 65(3):508-11. PubMed ID: 20089542
[TBL] [Abstract][Full Text] [Related]
14. Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B.
Escobar P; Matu S; Marques C; Croft SL
Acta Trop; 2002 Feb; 81(2):151-7. PubMed ID: 11801222
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasites.
Varela-M RE; Villa-Pulgarin JA; Yepes E; Müller I; Modolell M; Muñoz DL; Robledo SM; Muskus CE; López-Abán J; Muro A; Vélez ID; Mollinedo F
PLoS Negl Trop Dis; 2012; 6(4):e1612. PubMed ID: 22506086
[TBL] [Abstract][Full Text] [Related]
16. CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.
Sane SA; Shakya N; Haq W; Gupta S
J Antimicrob Chemother; 2010 Jul; 65(7):1448-54. PubMed ID: 20495208
[TBL] [Abstract][Full Text] [Related]
17. Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response.
Wadhone P; Maiti M; Agarwal R; Kamat V; Martin S; Saha B
J Immunol; 2009 Jun; 182(11):7146-54. PubMed ID: 19454711
[TBL] [Abstract][Full Text] [Related]
18. Combination of paromomycin and miltefosine promotes TLR4-dependent induction of antileishmanial immune response in vitro.
Das S; Rani M; Pandey K; Sahoo GC; Rabidas VN; Singh D; Das P
J Antimicrob Chemother; 2012 Oct; 67(10):2373-8. PubMed ID: 22761329
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages.
Voak AA; Standing JF; Sepúlveda N; Harris A; Croft SL; Seifert K
J Antimicrob Chemother; 2018 May; 73(5):1314-1323. PubMed ID: 29506127
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in Leishmania donovani.
Das R; Roy A; Dutta N; Majumder HK
Apoptosis; 2008 Jul; 13(7):867-82. PubMed ID: 18506627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
